News Focus
News Focus
Followers 120
Posts 9716
Boards Moderated 0
Alias Born 02/03/2018

Re: shadolane post# 367254

Monday, 01/24/2022 2:34:41 PM

Monday, January 24, 2022 2:34:41 PM

Post# of 447411
Shadolane, if Generic's finished product is what I believe it to be, then inferior hands down. Worse, HARMFUL! It took Amarin 10 years to figure out how to produce and deliver the final product with all the elements in tact. There's no way Generic's could replicate that. I'm certain the corrupt FDA never asked Generic's to prove all elements of their product is the same. Yet another egregious violation permitted by the FDA. There's no way that the FDA did a granular comparison. The FDA has no idea about nuanced purities Vascepa offers.

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News